Skip to content

Aptus at Home: Co-design of a Home-based Monitoring System for Anaemia

Aptus at Home: Co-design of a Home-based Monitoring System for Anaemia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03835364
Enrollment
25
Registered
2019-02-08
Start date
2018-04-13
Completion date
2021-01-15
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron Deficiency Anemia

Brief summary

Co-design of a home-based anaemia monitoring system with participants who have previous diagnosis of anaemia.

Detailed description

The device/ monitoring system being developed is called Aptus home. Aptus home measures the haemoglobin and haematocrit levels in blood from a single drop of blood. By measuring these blood parameters, participants are able to monitor anaemia in participants' homes. The use of the device will take place in the participant's home to simulate what the investigators believe will be the ideal location for people who would prefer to self-manage their condition. This study is a unique opportunity to gain feedback on the future design and development of a home-based monitoring system through user evaluation. As this is an adaptive/ iterative study design, this will give the Sponsor the opportunity to make changes to the user interface and user platform based on the feedback received from the end user.

Interventions

Single fingerprick to measure haemoglobin and haematocrit measurements using the Aptus Home, anaemia home monitoring system.

Sponsors

Entia Ltd
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Prior diagnosis of anaemia * Commitment to perform finger pricking to use the device every two weeks and complete 2 monthly questionnaires * Participant's willingness to participate in 1 to 1 interviews and, or focus groups * Understands and has a good level of spoken and written English

Exclusion criteria

* No prior diagnosis of anaemia * Not committed to perform two weekly finger pricks to use device and complete 2 monthly questionnaires * Unwilling to attend interviews and focus groups * Doesn't have a good level of written and spoken English

Design outcomes

Primary

MeasureTime frameDescription
Qualitative capture of user feedback- Questionnaires14 monthsUser feedback gathered from participants using the anaemia monitoring device in participants' homes will be used to inform the changes necessary to develop a successful home-based anaemia monitoring system.
Qualitative capture of user feedback- focus groups14 monthsUser feedback gathered from participants using the anaemia monitoring device in participants' homes will be used to inform the changes necessary to develop a successful home-based anaemia monitoring system.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026